-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Citius Oncology, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2021 to Q4 2024.
- Citius Oncology, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$6.66M, a 40.9% decline year-over-year.
- Citius Oncology, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$23.1M, a 591% decline year-over-year.
- Citius Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$21.1M, a 974% decline from 2023.
- Citius Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $2.42M, a 535% increase from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)